[Changes in the treatment of urogenital tuberculosis].
Potent antituberculosis drugs and new endourological measures have changed the concept of management of urogenital tuberculosis. This paper presents a report on 56 patients treated with rifampicin, ethambutol and isoniazid for 1 year. Therapy was started in hospital and continued on an ambulatory basis. Reconstructive surgery was carried out as early as 4-5 weeks after commencement of therapy, whereby only destroyed organs wee removed. Follow up continued at three-monthly intervals for a period of 2-5 years after completion of chemotherapy. All patients were cured.
Lipsky
H
H
Urologische Abteilung, Landeskrankenhaus Leoben.
Stadler
W
W
D000293:Adolescent; D000328:Adult; D000368:Aged; D000995:Antitubercular Agents / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D009392:Nephrectomy; D014401:Tuberculosis, Urogenital / Q000188:drug therapy* / Q000601:surgery
D000995:Antitubercular Agents
Wandlungen in der Behandlung der Urogenitaltuberkulose.